Kaarina, Finland

Metgen Oy

USPTO Granted Patents = 15



Forward Citations = 8

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Klara Birikh (14 out of 14 patents)

silverMedal Anu Minna Maaret Suonpää (9 out of 9 patents)

bronzeMedal Matti Wilhelm Heikkilä (4 out of 4 patents)

4.  Alexey Azhayev (2 out of 2 patents)

5.  Antoine Patrice Noel Mialon (1 out of 1 patent)

6.  Veera Kaarina Hämäläinen (1 out of 1 patent)

7.  Liji Sobhana Seleenmary Sobhanadhas (1 out of 1 patent)

8.  Antoine Patrice Noël Mialon (1 out of 1 patent)

9.  Tom Christian Lundin (1 out of 1 patent)

10.  Tanja Pauliina Saloranta (1 out of 1 patent)

11.  Joana Raquel Amaral Antunes (1 out of 1 patent)

12.  Anu Minna Maaret SuonpÄÄ (0 patent)


15 patents:

Company Overview
Metgen Oy is a Finnish biotechnology company specializing in the development of innovative enzymes for various industries, including pulp and paper, textiles, and biofuels. The company focuses on harnessing the power of nature to create sustainable solutions that enhance efficiency and reduce environmental impact. With a strong emphasis on research and development, Metgen aims to provide cutting-edge biotechnological applications that support the transition towards a circular economy, contributing to a greener future.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

15 Patents

#1 in Kaarina

#219 in Finland

#39,959 in the World

Kaarina, FI
Kaarina, Finland
Forward Citations = 8

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Metgen Oy. Retrieved from https://idiyas.com/company/metgen-oy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…